series-c-plus
Stage
1
Investors
About
Promedior is a clinical-stage biotechnology company developing targeted therapeutics to treat fibrotic diseases, including idiopathic pulmonary fibrosis (IPF).
Explore Promedior's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.